Neurocritical care constitutes a specialized medical domain dedicated to addressing and treating patients afflicted with critical neurological conditions. These conditions often entail severe injuries or diseases impacting the brain, spinal cord, or peripheral nerves, necessitating immediate and intensive medical attention. The principal objective of neurocritical care revolves around averting secondary brain damage and optimizing neurological function in individuals grappling with life-threatening neurological ailments. This entails meticulous monitoring of vital signs, neurological status, and intracranial pressure, alongside prompt interventions to forestall complications like cerebral edema, ischemia, or hemorrhage. Neurocritical care teams typically comprise multidisciplinary experts, including neurologists, neurosurgeons, critical care physicians, nurses, respiratory therapists, and pharmacists, collaborating synergistically to furnish comprehensive care to patients grappling with complex neurological disorders. Common conditions managed within neurocritical care units encompass traumatic brain injury, subarachnoid hemorrhage, ischemic and hemorrhagic stroke, status epilepticus, spinal cord injury, and severe neurological infections. Treatment modalities may entail neuroprotective measures, mechanical ventilation, intracranial pressure monitoring, vasopressor therapy, and neurosurgical interventions like decompressive craniectomy or clot evacuation. Neurocritical care also assumes a pivotal role in aiding patients through the acute phase of their illness and facilitating their transition to rehabilitation services or long-term care facilities. Additionally, neurocritical care research contributes to advancements in comprehending the pathophysiology of neurological diseases and devising innovative treatments to augment patient outcomes.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States